Moving Chemistry from Bench to Market
A number of Atomwise members were selected to present at this year's national meeting. From posters, presentation talks, or panel discussions, learn more about what our members have been doing in their presentation sessions below.
AIMS Program Collaborations
Through the AIMS Awards Program, Atomwise supports promising researchers with AI resources for small-molecule drug discovery that help advance their work. This year, a number of our research collaborations were selected to present at the ACS national meeting.
Abraham Heifets, PhD
Results From the World's Largest Distributed Prospective Application of Machine Learning to Small-Molecule Hit DiscoveryDIVISION
Computers in ChemistryLEARN MORE
Jeff Warrington, PhD
Identification of Mitochondrial RNA Polymerase Inhibitors via Deep Convolutional Neural Networks: A Therapeutic Strategy for Cancer MetabolismDIVISION
Steve Van Doren, PhD
University of Missouri
Targeting Invasion-Promoting Proteases MMP-7 and MMP-14 at Remote ExositesDIVISION
Denzil Bernard, PhD & Jeff Warrington, PhDLEARN MORE
Venkatesh Mysore, PhD
Billion Trawler Answer: A Scalable and Effective Machine Learning Based Solution for the Virtual High-Throughput Screening of Ultra-Large LibrariesDIVISION
Victoria Robinson, PhD
University of Connecticut
Combining Artificial Intelligence and High Throughputs Screening to Identify Modulators of the GTPase Activity of Prokaryotic Ribosome Binding Protein typADIVISION
Jeff Warrington, PhD
Join our team
Our team is comprised of over 30 PhD scientists who contribute to a high-performance academic-like culture that fosters robust scientific and technical excellence. We strongly believe that data wins over opinions, and aim for as little dogma as possible in our decision making. Learn more about our team and opportunities at Atomwise.
The AIMS Awards program, started in 2017, is designed to support promising researchers with resources that will help advance their work. AIMS Awards target research focused on finding solutions for complex human health conditions. To date, Atomwise has funded 5 rounds of AIMS Awards, completing over 100 collaborative projects and accepting over 775 projects into the program. Applications are accepted anytime.